Literature DB >> 23863178

Nuclear receptor-binding protein 1: a novel tumour suppressor and pseudokinase.

Jason S Kerr1, Catherine H Wilson.   

Abstract

Pseudokinases are a class of kinases which are structurally designated as lacking kinase activity. Despite the lack of kinase domain sequence conservation, there is increasing evidence that a number of pseudokinases retain kinase activity and/or have critical cellular functions, casting aside previous notions that pseudokinases simply exist as redundant kinases. Moreover, a number of recent studies have implicated pseudokinases as critical components in cancer formation and progression. The present review discusses the interactions and potential functions that nuclear receptor-binding protein 1, a pseudokinase recently described to have a tumour-suppressive role in cancer, may play in cellular homoeostasis and protein regulation. The recent findings highlighted in the present review emphasize the requirement to fully determine the function of pseudokinases in vitro and in vivo, the understanding of which may ultimately uncover new directions for drug discovery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23863178     DOI: 10.1042/BST20130069

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  7 in total

1.  Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2.

Authors:  Qiao Li; Pan Chen; Zhaoyang Zeng; Fang Liang; Yali Song; Fang Xiong; Xiayu Li; Zhaojian Gong; Ming Zhou; Bo Xiang; Cong Peng; Xiaoling Li; Xiang Chen; Guiyuan Li; Wei Xiong
Journal:  Tumour Biol       Date:  2016-06-23

2.  NRBP1 is downregulated in breast cancer and NRBP1 overexpression inhibits cancer cell proliferation through Wnt/β-catenin signaling pathway.

Authors:  Hong Wei; Hongbin Wang; Qiao Ji; Jiawei Sun; Lin Tao; Xianli Zhou
Journal:  Onco Targets Ther       Date:  2015-12-14       Impact factor: 4.147

3.  DNA hypomethylation of a transcription factor binding site within the promoter of a gout risk gene NRBP1 upregulates its expression by inhibition of TFAP2A binding.

Authors:  Zaihua Zhu; Weida Meng; Peiru Liu; Xiaoxia Zhu; Yun Liu; Hejian Zou
Journal:  Clin Epigenetics       Date:  2017-09-15       Impact factor: 6.551

4.  High NRBP1 expression promotes proliferation and correlates with poor prognosis in bladder cancer.

Authors:  Qi Wu; Xiaoqing Zhou; Peng Li; Wei Wang; Jun Wang; Mingyue Tan; Le Tao; Jianxin Qiu
Journal:  J Cancer       Date:  2019-07-10       Impact factor: 4.207

5.  NRBP1 negatively regulates SALL4 to reduce the invasion and migration, promote apoptosis and increase the sensitivity to chemotherapy drugs of breast cancer cells.

Authors:  Chao Yang; Xiangmei Zhang; Chao Gao; Kaiye Du; Yunjiang Liu
Journal:  Oncol Lett       Date:  2022-03-02       Impact factor: 2.967

6.  Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine.

Authors:  Wei Yao; Qianqian Cao; Shilin Luo; Lujuan He; Chun Yang; Jiaxu Chen; Qi Qi; Kenji Hashimoto; Ji-Chun Zhang
Journal:  Mol Psychiatry       Date:  2021-11-24       Impact factor: 13.437

7.  CircLRP6 contributes to prostate cancer growth and metastasis by binding to miR-330-5p to up-regulate NRBP1.

Authors:  Linghui Qin; Xiaosong Sun; Fei Zhou; Cheng Liu
Journal:  World J Surg Oncol       Date:  2021-06-22       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.